| 1 |
29436156 | Cytochrome P450 Genetic Variation Associated with Tamoxifen Biotransformation in American Indian and Alaska Native People. | 2018 May |
2 |
| 2 |
29479969 | Detection of Cytochrome P450 Polymorphisms in Breast Cancer Patients May Impact on Tamoxifen Therapy | 2018 Feb 26 |
3 |
| 3 |
26446141 | Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch. | 2016 Feb |
2 |
| 4 |
26896706 | Design and synthesis of novel tamoxifen analogues that avoid CYP2D6 metabolism. | 2016 Apr 13 |
2 |
| 5 |
27198207 | Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1. | 2016 Dec |
3 |
| 6 |
25940823 | Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen. | 2015 Aug |
2 |
| 7 |
26423799 | Comparative metabolic study between two selective estrogen receptor modulators, toremifene and tamoxifen, in human liver microsomes. | 2015 Oct |
1 |
| 8 |
24265353 | The rs1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in postmenopausal women on tamoxifen. | 2014 Jan |
4 |
| 9 |
25114852 | Impact of CYP2D*6 in the adjuvant treatment of breast cancer patients with tamoxifen. | 2014 Aug 10 |
2 |
| 10 |
22041137 | Pharmacogenomics of tamoxifen: roles of drug metabolizing enzymes and transporters. | 2012 |
4 |
| 11 |
22617226 | Effects of CYP induction by rifampicin on tamoxifen exposure. | 2012 Jul |
5 |
| 12 |
21226615 | Pharmacogenetics of endocrine therapy for breast cancer. | 2011 |
2 |
| 13 |
21750172 | Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors. | 2011 Sep |
1 |
| 14 |
20052538 | Orally administered endoxifen is a new therapeutic agent for breast cancer. | 2010 Jul |
2 |
| 15 |
20425602 | CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevance. | 2010 Jan |
2 |
| 16 |
20877451 | CYP2D6 testing to predict response to tamoxifen in women with breast cancer: Pharmacogenomic. | 2010 Sep 2 |
2 |
| 17 |
19574470 | Pharmacogenomics of tamoxifen therapy. | 2009 Oct |
2 |
| 18 |
17434921 | Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use. | 2007 Oct |
2 |
| 19 |
18001838 | Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. | 2007 Dec |
1 |
| 20 |
15596297 | Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients. | 2005 Jan 10 |
2 |
| 21 |
15111773 | Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen. | 2004 May |
6 |
| 22 |
15159443 | Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. | 2004 Sep |
1 |
| 23 |
14652237 | Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. | 2003 Dec 3 |
4 |
| 24 |
14678248 | Oxidative metabolism of tamoxifen to Z-4-hydroxy-tamoxifen by cytochrome P450 isoforms: an appraisal of in vitro studies. | 2003 Nov |
1 |
| 25 |
12124303 | Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen. | 2002 Aug |
2 |
| 26 |
9498238 | Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium. | 1998 Feb |
2 |
| 27 |
4004771 | Quantification of cytochrome P-450-dependent cyclohexane hydroxylase activity in normal and neoplastic reproductive tissues. | 1985 Apr 15 |
2 |
| 28 |
4061517 | Cytochrome P-450 activity in human leiomyoma and normal myometrium. | 1985 Nov 1 |
2 |